NAIROBI, Oct. 13 (Xinhua) -- Kenya's battle against malaria has gained new momentum through the widespread deployment of an injectable drug manufactured by the Chinese pharmaceutical company, Fosun Pharma, Kenyan officials said Thursday, during a forum in the western Kenyan city of Kisumu.
Kibor Keitany, the head of the National Malaria Control Program in the Ministry of Health, said that Fosun Pharma's second-generation artesunate for injection, marketed under the Argesun brand name, has proven effective in treating severe malaria cases.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
